Fidelity Advisor Biotechnology Fund - Class Z (FIJYX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
29.63
+0.13 (0.44%)
Jul 3, 2025, 4:00 PM EDT
-8.38%
Fund Assets 1.28B
Expense Ratio 0.61%
Min. Investment $0.00
Turnover 73.00%
Dividend (ttm) 1.75
Dividend Yield 5.90%
Dividend Growth 275.91%
Payout Frequency Annual
Ex-Dividend Date Dec 26, 2024
Previous Close 29.50
YTD Return -1.00%
1-Year Return -8.38%
5-Year Return 10.87%
52-Week Low 24.28
52-Week High 38.17
Beta (5Y) n/a
Holdings 85
Inception Date Oct 2, 2018

About FIJYX

Fidelity Advisor Biotechnology Fund Class Z is a mutual fund designed to achieve capital appreciation by investing primarily in biotechnology companies. The fund allocates at least 80% of its assets to firms engaged in the research, development, manufacture, and distribution of biotechnology products, services, and processes. It may invest in both domestic and foreign companies, targeting those poised to benefit significantly from scientific advancements in the field. The fund emphasizes exposure to innovative sectors within healthcare, such as pharmaceuticals and therapeutic development, and its portfolio is notably concentrated, with over half of assets in its top ten holdings, including industry leaders like AbbVie, Regeneron Pharmaceuticals, and Amgen. With a competitive expense ratio that falls among the lowest in its category, the fund is positioned as a cost-effective choice for investors seeking targeted exposure to the biotech sector. Its risk profile and performance have been rated above average, reflecting the sector’s volatility and growth potential. By focusing on a dynamic and fast-evolving industry, Fidelity Advisor Biotechnology Fund Class Z plays a specialized role in the market, offering diversification for those seeking to tap into biotechnological innovation and long-term trends in healthcare.

Fund Family Fidelity
Category Health
Stock Exchange NASDAQ
Ticker Symbol FIJYX
Share Class Class Z
Index S&P 500 TR

Performance

FIJYX had a total return of -8.38% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.82%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
FBTIX Class I 0.74%
FBTAX Class A 1.01%
FBTTX Class M 1.29%
FBTCX Class C 1.76%

Top 10 Holdings

60.00% of assets
Name Symbol Weight
AbbVie Inc. ABBV 19.38%
Gilead Sciences, Inc. GILD 8.75%
Alnylam Pharmaceuticals, Inc. ALNY 7.26%
Ascendis Pharma A/S ASND 5.53%
Amgen Inc. AMGN 5.25%
argenx SE ARGX 4.92%
Neurocrine Biosciences, Inc. NBIX 2.63%
Nuvalent, Inc. NUVL 2.38%
Vaxcyte, Inc. PCVX 1.99%
Viridian Therapeutics, Inc. VRDN 1.90%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 26, 2024 $1.748 Dec 27, 2024
Dec 21, 2023 $0.465 Dec 22, 2023
Dec 17, 2021 $5.440 Dec 20, 2021
Jul 9, 2021 $0.158 Jul 12, 2021
Dec 18, 2020 $2.963 Dec 21, 2020
Dec 20, 2019 $1.927 Dec 23, 2019
Full Dividend History